Erythema Nodosum Induced by the Pfizer- BioNTech Vaccine

Area of Science:

• Dermatology
• Immunology
• Vaccinology

Background:

• The Pfizer-BioNTech (Comirnaty) COVID-19 mRNA vaccine is widely administered.
• Adverse reactions to vaccines can occur, necessitating vigilant monitoring and reporting.

Observation:

• A 42-year-old male presented with acute onset of painful nodular dermatitis.
• Symptoms included a fever of 38.5°C and arthralgia.
• Onset occurred 8 days post-first dose of the Pfizer-BioNTech COVID-19 vaccine.

Findings:

• The patient reported no recent infections, inflammatory conditions, malignancies, or other drug administrations.
• The clinical presentation suggests a possible immune-mediated reaction linked to the vaccination.

Implications:

• This case highlights a potential rare dermatological adverse event following COVID-19 vaccination.
• Further research is warranted to understand the incidence and mechanisms of such reactions.
• Clinicians should consider vaccine-related side effects in patients presenting with similar acute symptoms post-immunization.